By Louisa Clarence-Smith Publication Date: 2026-01-28 23:01:00 Microsoft narrowly beat Wall Street’s quarterly sales expectations as companies developing and running…
AZURE-2 evaluates the efficacy and safety of brelovitug as a monotherapy compared head-to-head with Hepcludex (bulevirtide) Enrollment in AZURE-1, a global…
By Khac Phu Nguyen Publication Date: 2026-08-19 17:40:00 This article first appeared on GuruFocus. Microsoft (NASDAQ:MSFT), the enterprise-software, cloud and…